DK1735013T3 - Alfa- og beta-udsendende hydroxyapatitpartikler - Google Patents

Alfa- og beta-udsendende hydroxyapatitpartikler

Info

Publication number
DK1735013T3
DK1735013T3 DK05708405.5T DK05708405T DK1735013T3 DK 1735013 T3 DK1735013 T3 DK 1735013T3 DK 05708405 T DK05708405 T DK 05708405T DK 1735013 T3 DK1735013 T3 DK 1735013T3
Authority
DK
Denmark
Prior art keywords
alpha
hydroxyapatite particles
beta emitting
emitting hydroxyapatite
emitting radionuclide
Prior art date
Application number
DK05708405.5T
Other languages
Danish (da)
English (en)
Inventor
Gro Salberg
Roy Larsen
Original Assignee
Algeta Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algeta Asa filed Critical Algeta Asa
Priority claimed from PCT/GB2005/000616 external-priority patent/WO2005079867A2/en
Application granted granted Critical
Publication of DK1735013T3 publication Critical patent/DK1735013T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
DK05708405.5T 2004-02-20 2005-02-18 Alfa- og beta-udsendende hydroxyapatitpartikler DK1735013T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0403856.8A GB0403856D0 (en) 2004-02-20 2004-02-20 Composition
US54687804P 2004-02-23 2004-02-23
PCT/GB2005/000616 WO2005079867A2 (en) 2004-02-20 2005-02-18 Alpha-emitting hydroxyapatite particles

Publications (1)

Publication Number Publication Date
DK1735013T3 true DK1735013T3 (da) 2012-05-21

Family

ID=32040119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05708405.5T DK1735013T3 (da) 2004-02-20 2005-02-18 Alfa- og beta-udsendende hydroxyapatitpartikler

Country Status (13)

Country Link
JP (1) JP5214884B2 (de)
KR (2) KR20070038030A (de)
CN (1) CN1972720B (de)
AT (1) ATE544492T1 (de)
DK (1) DK1735013T3 (de)
ES (1) ES2382041T3 (de)
GB (1) GB0403856D0 (de)
IL (1) IL177354A (de)
NO (1) NO20064232L (de)
NZ (1) NZ549080A (de)
PT (1) PT1735013E (de)
TW (1) TWI347194B (de)
ZA (1) ZA200606728B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO3111959T3 (de) * 2015-07-03 2018-02-10
US20170065731A1 (en) * 2015-09-06 2017-03-09 Medical Theranostics Inc. Method, Apparatus, and System for Radiation Therapy
CN106344927A (zh) * 2016-09-27 2017-01-25 大连理工大学 叶酸修饰的载药羟基磷灰石及其制备方法
MX2023002801A (es) * 2020-09-15 2023-04-21 Oncoinvent As Particulas radiomarcadas de tama?o controlado.
EP4646235A1 (de) * 2023-01-05 2025-11-12 Oncoinvent AS Alpha-emittierende radionuklide zur verwendung bei der behandlung von peritonealkarzinom

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168015T1 (de) * 1990-12-21 1998-07-15 Mallinckrodt Medical Inc Zur strahlensynovektomie nützliche radionukleotidmarkierte teilchen
WO1995011694A1 (en) * 1993-10-26 1995-05-04 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
CZ293919B6 (cs) * 1999-10-18 2004-08-18 Ferxáincorporated Prostředek schopný reagovat na magnetické pole
JP3836444B2 (ja) * 2002-05-30 2006-10-25 独立行政法人科学技術振興機構 ハイドロキシアパタイト複合体およびその製造方法、ならびに、それを用いた医療用材料

Also Published As

Publication number Publication date
NO20064232L (no) 2006-09-19
JP2007528373A (ja) 2007-10-11
ES2382041T3 (es) 2012-06-04
NZ549080A (en) 2011-01-28
GB0403856D0 (en) 2004-03-24
TW200536558A (en) 2005-11-16
CN1972720B (zh) 2010-07-07
KR20100060029A (ko) 2010-06-04
CN1972720A (zh) 2007-05-30
ZA200606728B (en) 2007-12-27
TWI347194B (en) 2011-08-21
JP5214884B2 (ja) 2013-06-19
KR20070038030A (ko) 2007-04-09
KR101165518B1 (ko) 2012-07-16
IL177354A0 (en) 2006-12-10
PT1735013E (pt) 2012-05-08
IL177354A (en) 2013-04-30
ATE544492T1 (de) 2012-02-15

Similar Documents

Publication Publication Date Title
EA200601524A1 (ru) Альфа-излучающие частицы гидроксиапатита
MX383644B (es) Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion.
LTPA2017009I1 (lt) Brutono tirozinkinazės inhibitoriai
NO20003457L (no) Bensökende alfapartikkel emitterende radiofarmasöytika
PT1472541E (pt) Agentes de imagiologia e métodos de imagiologia de naaladase de psma
EP4582105A3 (de) Formulierungen von 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dion
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
WO2007149406A8 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
ATE544492T1 (de) Alpha- und beta-emittierende hydroxyapatit- teilchen
ATE412418T1 (de) Zusammensetzungen zur erhöhung der zahl antigen präsentierender zellen und der antitumoralen antwort in menschlichen patienten
EA200600987A1 (ru) Применение сирамезина в лечении злокачественных опухолей